All episodes
Ep213: Daphne Koller on The Moment in AI Drug Discovery
Ep212: Tim Shannon on Creating Targeted Protein Degraders as Medicines
Ep211: Ardem Patapoutian on Touch, Pain & New Discoveries in Neuroscience
Ep210: Cameron Turtle on Long-Lasting Antibodies for Immune Disorders
Ep209: Mathai Mammen on Developing Drugs Against Undruggable Targets
Ep208: Gary Nabel on Developing a Vaccine for Epstein-Barr Virus
Ep207: Jason Coloma on Genetic Medicines for Kidney Diseases
Ep206: Lyn Baranowski on Inhalable Medicines for Severe Lung Diseases
Ep205: Heather Turner on a Schizophrenia Drug Patients Can Stick With
Ep204: Troy Wilson on Precision Cancer Drugs and Combos
Ep203: Sri Kosuri on Small Molecule Correctors of Disease
Ep202: Becky Pferdehirt on Reimagining Science for the AI Era
Ep201: Jeremy Levin on Biotech in the Balance
Ep200: Richard Pops Reflects on a 35-Year Career in Biotech
Ep199: Martin Burke on Making Small Molecule Medicines for the AI Era
Ep198: Abbas Kazimi on Computation and Culture for Drug Discovery
Ep197: Viswa Colluru on Discovering Drugs Inspired by Mother Nature
Ep196: Otello Stampacchia on Europe's Biotech Crisis
Ep195: Ken Song on T-cell Engagers for Autoimmune Diseases
Ep194: Ansu Satpathy on Cancer and Autoimmune Drug Discovery
Ep193: Ron Renaud on Helping People Lose Weight With GLP-1 Medicines
Ep192: Kate Haviland on Following the Science to Precision Immunology
Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
Ep190: Neil Kumar on Building a Rare Disease Drug Company
Ep189: Marc Tessier-Lavigne on Reinventing Drug Discovery with AI
Ep188: Art Krieg on Innate Immune System Activators for Cancer
Ep187: Eric Fischer on Creating a New Class of Medicines
Ep186: Bruce Levine & Mags McCarthy on a Song About Science and Hope
Ep185: Dr. Lachelle Weeks on Predicting Leukemia Risk At Scale
Ep184: Jen Adair on Affordable, Accessible Gene & Cell Therapies
Ep183: Sabah Oney on CAR-T Cells Against Solid Tumors
Ep182: Andy Rachleff & Yung Lie on Creative Ways to Back Science
Ep181: Claire Mazumdar on a Two-Pronged Attack Against Cancer
Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNA
Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & Diabetes
Ep178: Peyton Greenside on ML-Guided Biologics Discovery
Ep177: Kevin Parker on Finding Cancer Drug Targets
Ep176: David Roblin on Building a TechBio Company
Ep175: Andy Scharenberg on in vivo CAR-T cell therapies
Ep174: Najat Khan on the TechBio Movement
Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle Disorders
Ep172: Mostafa Ronaghi on Studying Live Cells at Scale
Ep171: Ram Aiyar on RNA Editing Medicines
Ep170: David Schenkein on Investing in the Future of Biotech
Ep169: Kevin Fitzgerald on the Past & Future of RNAi Medicines
Ep168: Jonathan Bricker on How to Quit Smoking & Prevent Cancer
Ep167: Leslie Williams on transfer RNA therapies
Ep166: Chris Garcia on Engineering Protein Drugs for Cancer, Autoimmunity
Ep165: Zach Hornby on Tackling Cancer Drug Resistance
Ep164: Ted Love and Alan Anderson on Raising the Bar for Sickle Cell Disease Patients
Ep163: Sarah Boyce on RNA Medicines for Muscle Diseases
Ep162: Sean McClain on AI for Biologic Drug Discovery
Ep161: Jeff Stein on a Long-Lasting Flu Drug
Ep160: Abe Ceesay on Precision Neuroscience
Ep159: Jimi Olaghere on Being Functionally Cured of Sickle Cell Disease
Ep158: David Younger and Randolph Lopez on SynBio & AI for Discovery
Ep157: Vineeta Agarwala of A16Z on Investing in AI for Drug Discovery
Ep156: David Liu on New Tools and Techniques for Biology
Ep155: Valerie Daggett on Early Detection, and Treatment, of Alzheimer's
Ep154: Robert Ang on CRISPR to Protect Bone Marrow & Attack Cancer
Ep153: Rick Young on Studying Gene Expression for Drug Discovery
Ep152: Jens Eckstein on Investing in Healthy Aging
Ep151: Shelley Force Aldred and Nathan Trinklein on Bispecific Antibodies for Cancer
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
Ep149: Nancy Stagliano on Precision Neuroscience
Ep148: Diana Brainard on the Fight Against Infectious Disease
Ep147: Reid Huber on Investing in the Future of Medicine
Ep146: Jeff Huber on Life in Tech and Biotech
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
Ep144: Turning the Tables, Rob Perez Interviews Me
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
Ep139: Kevin Conroy on Early Detection of Cancer
Ep138: Jodie Morrison on Becoming a Biotech CEO
Ep137: Aaron Ring on Immunotherapy for Cancer & More
Ep136: Deborah Palestrant on Building Biotech Startups
Ep135: John Maraganore on Developing a New Class of Medicines
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
Ep132: Eric Dobmeier on Treating Kidney Disease
Ep131: Ryan Watts on Neuroscience Drug R&D
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
Ep127: Jeb Keiper on Computational Drug Discovery
Ep126: DA Wallach on Becoming a Biotech VC
Ep125: Barry Greene on a New Drug for Depression
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
Ep120: Tim Lu on Gene Circuits for Cell Therapy
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
Ep115: Rahul Singhvi on Reimagining Biotech Manufacturing
Ep114: Chris Gibson on Industrializing Drug Discovery